CoChat
Sign Up
Cited by 23

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures

Ma, Jing, Alzheimer's Disease Neuroimaging Initiative, Zhang, Wei, Tan, Lin, Wang, Hui-Fu, Wan, Yu, Sun, Fu-Rong, Tan, Chen-Chen, Yu, Jin-Tai, Tan, Lan·2016·Oncotarget
DOI 10.18632/oncotarget.9563PMC PMC5312275
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.9563

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The significant correlation between MS4A6A loci and morphological changes of AD specific structure on MRI in all group analysis Figure 2A-2C depicted that rs610932 was associated with the atrophy rate of left middle temporal, left precuneus and left entorhinal in one year follow-up study. Figure 2D depicted that rs7232 was associated with the atrophy rate of left middle temporal after one-year follow-up.
Figure 1 The significant correlation between MS4A6A loci and morphological changes of AD specific structure on MRI in all group analysis Figure 2A-2C depicted that rs610932 was associated with the atrophy rate of left middle temporal, left precuneus and left entorhinal in one year follow-up study. Figure 2D depicted that rs7232 was associated with the atrophy rate of left middle temporal after one-year follow-up.CC BY · PubMed Central
Figure 2 The significant correlation between rs610932 and morphological changes of AD specific structure on MRI in subgroup analysis after one-year follow-up Figure 2A-2C depicted that rs610932 was associated with the atrophy rate of left middle temporal, left entorhinal and left precuneus in MCI group. Figure 4D depicted that rs610932 was associated with the atrophy rate of left entorhinal in NC group.
Figure 2 The significant correlation between rs610932 and morphological changes of AD specific structure on MRI in subgroup analysis after one-year follow-up Figure 2A-2C depicted that rs610932 was associated with the atrophy rate of left middle temporal, left entorhinal and left precuneus in MCI group. Figure 4D depicted that rs610932 was associated with the atrophy rate of left entorhinal in NC group.CC BY · PubMed Central
Figure 3 The significant correlation between rs7232 and morphological changes of AD specific structure on MRI in MCI group after one-year follow-up
Figure 3 The significant correlation between rs7232 and morphological changes of AD specific structure on MRI in MCI group after one-year follow-upCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 46

  1. Tan, 2013, Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors, Current Alzheimer research, 10, 852, 10.2174/15672050113109990155 · DOI
  2. Maier, 2015, Epidemiological and economic burden of Alzheimer's disease: a systematic literature review of data across Europe and the United States of America, Journal of Alzheimer's disease, 43, 1271
  3. Lange, 2001, Cognitive screening and neuropsychological assessment in early Alzheimer's disease, Clin Geriatr Med, 17, 229, 10.1016/S0749-0690(05)70067-7 · DOI
  4. Francisco, 2010, Non steroidal anti-inflammatory drugs prescription in General Practice in the centre of Portugal from 2007 to 2009, Acta reumatologica portuguesa, 35, 447
  5. Barletta, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Annals of neurology, 55, 306, 10.1002/ana.20009 · DOI · Paper page
  6. Petersen, 2008, 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment, Brain, 131, 665, 10.1093/brain/awm336 · DOI · Paper page
  7. Hulshoff Pol, 2007, Genetic influences on human brain structure: a review of brain imaging studies in twins, 6924 Hum Brain Mapp, 28, 464
  8. Yu, 2015, Rate of early onset Alzheimer's disease: a systematic review and meta-analysis, Annals of translational medicine, 3, 38
  9. Tan, 2014, Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease, PloS one, 9, e114777, 10.1371/journal.pone.0114777 · DOI
  10. Yu, 2015, Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders, Molecular neurobiology
  11. Yu, 2015, Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease, Journal of Alzheimer's disease, 46, 491, 10.3233/JAD-150110 · DOI
  12. Stretton, 2011, Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease, Nature genetics, 43, 429, 10.1038/ng.803 · DOI · Paper page
  13. Cui, 2013, Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population, Alzheimer's & dementia, 9, 546, 10.1016/j.jalz.2012.08.007 · DOI
  14. Chen, 2012, The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease, Human genetics, 131, 1245, 10.1007/s00439-012-1154-6 · DOI
  15. Chaim, 2014, Control of hypertension after roux-en-y gastric bypass among obese diabetic patients, Arquivos de gastroenterologia, 51, 21, 10.1590/S0004-28032014000100005 · DOI
  16. Yu, 2016, Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts, Molecular neurobiology
  17. Yu, 2016, Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer's Disease Cohorts, Molecular neurobiology
  18. Yu, 2016, Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer's Disease, Molecular neurobiology
  19. Yu, 2016, Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment, Molecular neurobiology
  20. Yu, 2016, GWAS-Linked Loci and Neuroimaging Measures in Alzheimer's Disease, Molecular neurobiology
  21. Vellas, 2014, Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood, Neurobiology of aging, 35, 279, 10.1016/j.neurobiolaging.2013.08.002 · DOI · Paper page
  22. Ma, 2012, Novel late-onset Alzheimer disease loci variants associate with brain gene expression, Neurology, 79, 221, 10.1212/WNL.0b013e3182605801 · DOI
  23. Leinonen, 2015, Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models, Neurobiology of aging, 36, e1215
  24. AddNeuroMed, 2009, MRI measures of Alzheimer's disease and the AddNeuroMed study, Annals of the New York Academy of Sciences, 1180, 47, 10.1111/j.1749-6632.2009.05063.x · DOI
  25. Cotman, 1991, Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease, Neurology, 41, 51, 10.1212/WNL.41.1.51 · DOI
  26. George, 1997, Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease, Neurobiology of aging, 18, 131, 10.1016/S0197-4580(97)00001-8 · DOI · Paper page
  27. Kokmen, 1998, Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease, Neurology, 51, 993, 10.1212/WNL.51.4.993 · DOI · Paper page
  28. Kinzler, 2002, Allelic variation in human gene expression, Science (New York, NY), 297, 1143, 10.1126/science.1072545 · DOI
  29. Vellas, 2014, Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood, Neurobiology of aging, 35, 279, 10.1016/j.neurobiolaging.2013.08.002 · DOI · Paper page
  30. Reiser, 2011, Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection, Antioxidants & redox signaling, 14, 1275, 10.1089/ars.2010.3359 · DOI
  31. Cho, 2011, Sensing change: the emerging role of calcium sensors in neuronal disease, Seminars in cell & developmental biology, 22, 530, 10.1016/j.semcdb.2011.07.014 · DOI
  32. Garaschuk, 2010, Intracellular calcium signalling in Alzheimer's disease, Journal of cellular and molecular medicine, 14, 30, 10.1111/j.1582-4934.2009.00976.x · DOI
  33. Vingtdeux, 2009, Calcium signaling in neurodegeneration, Molecular neurodegeneration, 4, 20, 10.1186/1750-1326-4-20 · DOI
  34. LaFerla, 2002, Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease, Nature reviews Neuroscience, 3, 862, 10.1038/nrn960 · DOI
  35. Deans, 2013, Expression of MS4A and TMEM176 Genes in Human B Lymphocytes, Frontiers in immunology, 4, 195
  36. Deans, 2010, Phylogenetic analysis of the MS4A and TMEM176 gene families, PloS one, 5, e9369, 10.1371/journal.pone.0009369 · DOI
  37. Tan, 2015, MS4A Cluster in Alzheimer's Disease, Molecular neurobiology, 51, 1240, 10.1007/s12035-014-8800-z · DOI
  38. European Alzheimer's Disease I, Genetic, Environmental Risk in Alzheimer's D, Alzheimer's Disease Genetic C, Cohorts for H Aging Research in Genomic E, 2013, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease, Nature genetics, 45, 1452, 10.1038/ng.2802 · DOI · Paper page
  39. John, 2011, Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment, Translational psychiatry, 1, e54, 10.1038/tp.2011.50 · DOI
  40. Jimenez-Velazquez, 2015, Rare coding mutations identified by sequencing of Alzheimer's disease GWAS loci, Annals of neurology
  41. Koh, 2013, Association of GWAS top hits with late-onset Alzheimer disease in Korean population, Alzheimer disease and associated disorders, 27, 250, 10.1097/WAD.0b013e31826d7281 · DOI
  42. Noguera-Perea, 2011, The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease, Genome medicine, 3, 33, 10.1186/gm249 · DOI
  43. Shen, 2011, Multimodal classification of Alzheimer's disease and mild cognitive impairment, NeuroImage, 55, 856, 10.1016/j.neuroimage.2011.01.008 · DOI
  44. Jagust, 2011, Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI, Neurobiology of aging, 32, 1207, 10.1016/j.neurobiolaging.2009.07.002 · DOI · Paper page
  45. Jagust, 2009, Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects, Brain, 132, 1310
  46. Benjamini, 1990, More powerful procedures for multiple significance testing, Statistics in medicine, 9, 811, 10.1002/sim.4780090710 · DOI · Paper page

Cited by

Sorted by citations

See all 23

Metadata

Authors
Ma, J., Initiative, A. D. N., Zhang, W., Tan, L., Wang, H.-F., Wan, Y., Sun, F.-R., Tan, C.-C., Yu, J.-T., & Tan, L.
Affiliations
  • Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China
  • College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China
Venue
Oncotarget
Publisher
Impact Journals, LLC
Published
2016-05-23
Volume
7
Issue
37
Pages
58779-58788
ISSN
1949-2553
DOI
10.18632/oncotarget.9563
PMC
PMC5312275
Cited by
23
References
10
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review